Kyle M Fargen1, Dan Neal1, David J Fiorella2, Aquilla S Turk3, Michael Froehler4, J Mocco5. 1. Department of Neurosurgery, University of Florida, Gainesville, Florida, USA. 2. Cerebrovascular Center, Department of Neurosurgery, Stony Brook University Medical Center, Stony Brook, NY, USA. 3. Department of Radiology, Medical University of South Carolina, Charleston, South Carolina, USA. 4. Cerebrovascular Program, Vanderbilt University, Nashville, Tennessee, USA. 5. Department of Neurosurgery, New York, New York, USA.
Abstract
INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS). However, previous trials have provided mixed results regarding the efficacy of endovascular treatment for AIS. A meta-analysis of all available trial data was performed to summarize the available evidence. METHODS: A literature search was performed to identify all prospective RCTs comparing endovascular therapies with medical management for AIS. Two datasets were created: (1) all patients randomized after confirmation of large vessel occlusion (LVO) (consistent with the contemporary standard of practice at the majority of centers); and (2) all patients with outcome data who underwent randomization regardless of qualifying vascular imaging. The pre-specified primary outcome measure was modified Rankin Scale score of 0-2 at 90 days. A fixed-effect model was used to determine significance. RESULTS: Five prospective RCTs comparing endovascular therapies with medical management were included in dataset 1 (1183 patients) and six were included in dataset 2 (1903 total patients). Endovascular therapies were associated with significantly improved outcomes compared with medical management (OR 1.67, 95% CI 1.29 to 1.16, p=0.0001) for patients with LVO (dataset 1). This benefit persisted when patients from all six RCTs were included, even in the absence of confirmation of LVO (OR 1.27, 95% CI 1.05 to 1.54, p=0.019; dataset 2). CONCLUSIONS: A meta-analysis of prospective RCTs comparing endovascular therapies with medical management demonstrates superior outcomes in patients randomized to endovascular therapy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS). However, previous trials have provided mixed results regarding the efficacy of endovascular treatment for AIS. A meta-analysis of all available trial data was performed to summarize the available evidence. METHODS: A literature search was performed to identify all prospective RCTs comparing endovascular therapies with medical management for AIS. Two datasets were created: (1) all patients randomized after confirmation of large vessel occlusion (LVO) (consistent with the contemporary standard of practice at the majority of centers); and (2) all patients with outcome data who underwent randomization regardless of qualifying vascular imaging. The pre-specified primary outcome measure was modified Rankin Scale score of 0-2 at 90 days. A fixed-effect model was used to determine significance. RESULTS: Five prospective RCTs comparing endovascular therapies with medical management were included in dataset 1 (1183 patients) and six were included in dataset 2 (1903 total patients). Endovascular therapies were associated with significantly improved outcomes compared with medical management (OR 1.67, 95% CI 1.29 to 1.16, p=0.0001) for patients with LVO (dataset 1). This benefit persisted when patients from all six RCTs were included, even in the absence of confirmation of LVO (OR 1.27, 95% CI 1.05 to 1.54, p=0.019; dataset 2). CONCLUSIONS: A meta-analysis of prospective RCTs comparing endovascular therapies with medical management demonstrates superior outcomes in patients randomized to endovascular therapy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Jens Fiehler; Christophe Cognard; Mauro Gallitelli; Olav Jansen; Adam Kobayashi; Heinrich P Mattle; Keith W Muir; Mikael Mazighi; Karl Schaller; Peter D Schellinger Journal: Eur Stroke J Date: 2016-07-26
Authors: James P Rhudy; Marie A Bakitas; Kristiina Hyrkäs; Rita A Jablonski-Jaudon; Erica R Pryor; Henry E Wang; Anne W Alexandrov Journal: Brain Behav Date: 2015-09-23 Impact factor: 2.708
Authors: Bruce C V Campbell; Michael D Hill; Marta Rubiera; Bijoy K Menon; Andrew Demchuk; Geoffrey A Donnan; Daniel Roy; John Thornton; Laura Dorado; Alain Bonafe; Elad I Levy; Hans-Christoph Diener; María Hernández-Pérez; Vitor Mendes Pereira; Jordi Blasco; Helena Quesada; Jeremy Rempel; Reza Jahan; Stephen M Davis; Bruce C Stouch; Peter J Mitchell; Tudor G Jovin; Jeffrey L Saver; Mayank Goyal Journal: Stroke Date: 2016-03 Impact factor: 7.914
Authors: Joyce S Balami; Brad A Sutherland; Laurel D Edmunds; Iris Q Grunwald; Ain A Neuhaus; Gina Hadley; Hasneen Karbalai; Kneale A Metcalf; Gabriele C DeLuca; Alastair M Buchan Journal: Int J Stroke Date: 2015-08-26 Impact factor: 5.266